Litcius/Paper detail

Anticoagulation in COVID-19

Charlotte A Bradbury, Zoe McQuilten

2021The Lancet25 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAntithromboticThrombosisClinical trialVenous thrombosisAcute respiratory distressIntensive care medicineInternal medicineClinical PracticeFibrinolytic agentAnticoagulantVenous thromboembolismCardiologyDeep veinRespiratory distressLow molecular weight heparinRandomized controlled trialPathogenesisAdverse effectClinical efficacyCOVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementLong-Term Effects of COVID-19
Anticoagulation in COVID-19 | Litcius